Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
about
Psychotropic substance-seeking: evolutionary pathology or adaptation?Systemic conditions associated with areca nut usage: a literature review.Anthropological perspectives on use of the areca nut.A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouseChewing betel quid and the risk of metabolic disease, cardiovascular disease, and all-cause mortality: a meta-analysis.Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumersPotential action of betel alkaloids on positive and negative symptoms of schizophrenia: a review.Quantification of Salivary Arecoline, Arecaidine and N-Methylnipecotic Acid Levels in Volunteers by Liquid Chromatography-Tandem Mass Spectrometry.Effects of aqueous extracts of "Betel quid" and its constituents on testosterone production by dispersed mouse interstitial cells.Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers.Effect of arecoline on regeneration of injured peripheral nerves.Formulation optimization of arecoline patches.Twenty years of cholinergic intervention in Alzheimer's disease: A tale of disappointment and ultimate confidence.Effects of arecoline in relaxing human umbilical vessels and inhibiting endothelial cell growth.
P2860
Q34124591-32B5A2F4-B8FD-4C2E-828A-3568C929B0A4Q34129920-482CEF17-ECA6-4FDB-9333-B0946F6E951FQ34568465-63A9439C-38AD-4917-8342-D2EF110CD9C7Q34696359-1467F3E2-31DE-4F5C-9E1C-1D441D343FC4Q34935731-F81315B0-78FB-498B-AD51-02AB193A0012Q37139209-6745DE83-05E1-4EDC-9D6E-CE28E31EABF1Q37920918-66FA34BA-AD91-40F0-AD69-8DE991F91C13Q38978835-4D59C8DA-EE9B-40B4-AF51-CCD3BAB2EB0EQ42472562-E930DFEE-232C-4B83-987E-50294EB5F6F3Q47708275-1DD54A96-31B9-4E1C-8CC7-F3036DCD5518Q47911564-877F4F15-AD72-4B7A-B8BF-0523BE8CB6ACQ51096139-2FFEBD82-B295-4C6A-9C06-2F3516F515D7Q52041002-A1C5A62D-D8AB-4373-B162-729850661B3CQ53652557-FC99E90D-4443-4464-8733-1B7E2F08EE02
P2860
Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
@en
Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
@nl
type
label
Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
@en
Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
@nl
prefLabel
Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
@en
Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
@nl
P2093
P2860
P1476
Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
@en
P2093
Holloway HW
Raffaele KC
Schapiro MB
Soncrant TT
P2860
P304
P356
10.1016/S0009-9236(96)90054-5
P407
P577
1996-09-01T00:00:00Z